ATS 2024 Final Program

Click on the session title to view the speakers

SUNDAY • MAY 19

95

• recognize when blastomycosis should be considered as a potential cause for outbreaks of pneumonia. • describe new findings about silicosis related to working with engineered stone. The session will provide attendees with an overview of NIOSH’s unique authorities to study and address occupational respiratory diseases through health hazard evaluations and field studies and examples of efforts to address contemporary work-related outbreaks of blastomycosis and engineered stone-related silicosis. 12:00 Introduction to Session 12:03 Overview of NIOSH Authority to Conduct Health Hazard Evaluations and Industry-Wide Studies 12:22 Health Hazard Evaluation: Blastomycosis Outbreak in a Paper Mill 12:41 Industry-Wide Study: Respirable Crystalline Silica Exposure and Silicosis in Engineered Stone Workers MD11 SYSTEMS BIOLOGY IN INFECTIOUS DISEASES 12:00 p.m. - 1:00 p.m. San Diego Convention Center Room 2 (Upper Level) Target Audience Pulmonary, critical care and infectious diseases researchers, clinical/translational and basic sciences Objectives At the conclusion of this session, the participant will be able to: • apply a systems biology approach to studying clinical infectious disease outcomes. • define strategies to improve the ability to model lung immunity. • increase their awareness of NIH resources for studies of host immunity and microbial pathogenesis. The NIH/NIAID employs a variety of funding mechanisms to support research in serious infections, including severe viral, fungal, tuberculosis, and antibiotic-resistant bacterial pathogen infections. A systems biology approach to these pathogens, host NIH/NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES MID-DAY SESSION

response, and diseases relevant to the pulmonary and critical care community will be illustrated. 12:00 T Cell Responses During Severe SARS-CoV-2 Pneumonia 12:13 Decoding Persistent MRSA and Candida Bloodstream Infections 12:26 Dissecting the Viral Immunosphere Using Systems Serology and Viral Genomics 12:39 Code-A-Thon As a Model to Handle Big Data Analysis 12:52 Questions MD12 THE NHLBI LUNG TRANSPLANT CONSORTIUM 12:00 p.m. - 1:00 p.m. Target Audience Those with research interests involving the study of lung transplant donors or recipients. Objectives At the conclusion of this session, the participant will be able to: • learn about the impact of certain clinical practices on, and the value of, collecting particular data elements to inform, donor lung utilization and early post-transplant outcomes in lung transplant recipients • increase awareness among the broader lung transplant research community of the availability of the consortium’s resources to support ancillary studies. • be able to more appropriately design and control for clinical variables during the conduct of multi-site research studies involving lung transplant donors or recipients. This session will review recent research findings generated by investigators within the NHLBI Lung Transplant Consortium, which encompasses a series of observational cohort studies that aim to understand the impact of site-specific lung transplant selection criteria and clinical management strategies on donor lung utilization and/or early post-transplant outcomes in recipient 12:00 The PROMISE-LUNG Study Marriott Marquis San Diego Marina Grand Ballroom 11-13 (Lobby Level, North Tower) NHLBI, NIH MID-DAY SESSION

ATS 2024 Conference Program • San Diego, CA